Sign Up to like & get
recommendations!
0
Published in 2019 at "Pharmaceutical Development and Technology"
DOI: 10.1080/10837450.2019.1700520
Abstract: Abstract Febuxostat (FBX) is used to treat gout and chronic hyperuricemia. However, its bioavailability is moderate (49%) as a result of low solubility and first-pass metabolism. Therefore, the aim of our study is to improve…
read more here.
Keywords:
transdermal film;
vivo;
fbx;
film ... See more keywords